TLR4 and epilepsy: The risk of developing epilepsy, aggravating seizures frequency are strongly linked to peripheral inflammatory disorders in humans and animal studies, with the latter demonstrating an association between peripheral inflammatory bowel disorders and peripheral injection of Toll-like receptor 4 (TLR4) ligand lipopolysaccharide (LPS) and increased seizures frequency and their injuries [2].